Attention deficit hyperactivity disorder and Pharyngitis streptococcal
Summary:
Pharyngitis streptococcal is found among people with Attention deficit hyperactivity disorder, especially for people who are male, 2-9 old.
The study analyzes which people have Pharyngitis streptococcal with Attention deficit hyperactivity disorder. It is created by eHealthMe based on reports of 89 people who have Attention deficit hyperactivity disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
89 people who have Attention Deficit Hyperactivity Disorder and Pharyngitis Streptococcal are studied.
What is Attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 1,564 drugs and 1,273 conditions by eHealthMe.
What is Pharyngitis streptococcal?
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus) is found to be associated with 1,192 drugs and 585 conditions by eHealthMe.
Number of Pharyngitis streptococcal in Attention deficit hyperactivity disorder reports submitted per year:

Gender of people who have Attention Deficit Hyperactivity Disorder and experienced Pharyngitis Streptococcal *:
- female: 44.32 %
- male: 55.68 %
Age of people who have Attention Deficit Hyperactivity Disorder and experienced Pharyngitis Streptococcal *:
- 0-1: 0.0 %
- 2-9: 36.25 %
- 10-19: 36.25 %
- 20-29: 3.75 %
- 30-39: 6.25 %
- 40-49: 7.5 %
- 50-59: 10.0 %
- 60+: 0.0 %
Common co-existing conditions for these people *:
- Depression: 11 people, 12.36%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 7.87%
- Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 6 people, 6.74%
- Sleep Disorder: 6 people, 6.74%
- Asthma: 6 people, 6.74%
- High Blood Cholesterol: 5 people, 5.62%
- Stress And Anxiety: 5 people, 5.62%
- Muscle Spasms (muscle contraction): 5 people, 5.62%
- Psoriasis (immune-mediated disease that affects the skin): 4 people, 4.49%
- Insomnia (sleeplessness): 4 people, 4.49%
Common drugs taken by these people *:
- Strattera: 36 people, 40.45%
- Humira: 11 people, 12.36%
- Concerta: 8 people, 8.99%
- Prozac: 8 people, 8.99%
- Vyvanse: 7 people, 7.87%
- Adderall 10: 6 people, 6.74%
- Ritalin: 6 people, 6.74%
- Singulair: 6 people, 6.74%
- Daytrana: 5 people, 5.62%
- Amoxicillin: 5 people, 5.62%
Common symptoms for these people *:
- Breathing Difficulty: 11 people, 12.36%
- Fatigue (feeling of tiredness): 11 people, 12.36%
- Nausea And Vomiting: 9 people, 10.11%
- Cough: 9 people, 10.11%
- Malaise (a feeling of general discomfort or uneasiness): 9 people, 10.11%
- Weight Decreased: 9 people, 10.11%
- Drug Ineffective: 9 people, 10.11%
- Fever: 9 people, 10.11%
- The Flu (the flu is caused by an influenza virus): 8 people, 8.99%
- Stress And Anxiety: 8 people, 8.99%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Pharyngitis streptococcal?
Check whether Pharyngitis streptococcal is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Related studies
Treatments, associated drugs and conditions:
- Attention deficit hyperactivity disorder (107,554 reports)
- Pharyngitis streptococcal (10,686 reports)
COVID vaccines that are related to Pharyngitis streptococcal:
- Pharyngitis streptococcal in Moderna COVID Vaccine
- Pharyngitis streptococcal in Pfizer BioNTech Covid Vaccine
- Pharyngitis streptococcal in Johnson and Johnson Covid Vaccine
Common drugs associated with Pharyngitis streptococcal:
- Humira: 1,289 reports
- Enbrel: 1,239 reports
- Methotrexate: 778 reports
- Prednisone: 753 reports
- Cosentyx: 472 reports
- Tysabri: 347 reports
- Diphen: 337 reports
- Singulair: 302 reports
- Synthroid: 257 reports
- Tylenol: 255 reports
All the drugs that are associated with Pharyngitis streptococcal:
- Pharyngitis streptococcal (1,192 drugs)
Common conditions associated with Pharyngitis streptococcal:
- Rheumatoid arthritis: 1,242 reports
- Psoriasis: 942 reports
- Multiple sclerosis: 767 reports
- Crohn's disease: 741 reports
- Asthma: 337 reports
- Ulcerative colitis: 272 reports
- Ankylosing spondylitis: 222 reports
- High blood pressure: 220 reports
All the conditions that are associated with Pharyngitis streptococcal:
- Pharyngitis streptococcal (585 conditions)
How the study uses the data?
The study is based on Pharyngitis streptococcal and Attention deficit hyperactivity disorder, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Bleomycin Sulfate and Encephalitis - a second ago
- Crestor and Skin Atrophy - 7 seconds ago
- Losartan Potassium And Hydrochlorothiazide and Nervous System Disorder - 14 seconds ago
- Fluoxetine and Pre-Eclampsia Aggravated - 14 seconds ago
- Hepatic Function Abnormal and pfizer biontech covid vaccine - 24 seconds ago
- High Blood Pressure and Bleeding Disorders - 24 seconds ago
- Protonix and Conductive Deafness - 27 seconds ago
- Coronary Heart Disease and Splenomegaly - 35 seconds ago
- Klor-Con M10 and Hypotension Aggravated - 35 seconds ago
- Glucophage Xr and Purpura - 37 seconds ago